Separation of oligonucleotides modified with disulfides
Feb 26 2020 Read 712 Times
Antisense DNA and siRNA are widely used for gene silencing in research and medical applications. An effective delivery of the oligonucleotides into cells is important for clinical applications. As oligonucleotides are negatively charged the efficiency of the cell membrane permeability is low. Previous methods took several hours to deliver oligonucleotides to cytoplasm. According to Zhaome Shu et al, oligonucleotides modified with low molecular weight disulfide groups at their terminal residues reached the cytoplasm in 10 minutes as a result of disulfide exchange reactions with the thiol groups on cell surface.
Due to the hydrophobic character of the disulfide units, a less hydrophobic stationary phase is necessary for the analysis of the modified oligonucleotides. Even C18 columns with lower hydrophobicity achieve poor peak shapes. Also, the target disulfide modified oligonucleotides are not completely eluted. In this application good peak shapes are achieved using the less hydrophobic, widepore YMC-Triart Bio C4 column. The disulfide modified oligonucleotides were analysed using 50 mM TEAA buffer/acetonitrile and acetonitrile as eluents at an elevated temperature of 50°C
Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.
In This Edition Articles Fundamental Aspects - Separation of the 4 Enantiomers of the Fungicide Spiroxamine by LC-MS/MS - Optimising the Chiral Separation of the Pesticide Diniconazole...
View all digital editions
Sep 08 2020 Sheffield, UK
Sep 14 2020 Virtual Symposium
Sep 21 2020 Budapest, Hungary
Sep 27 2020 Saint-Malo, France
Sep 28 2020 Bethesda, MD, USA